STONY BROOK, N.Y.--(EON: Enhanced Online News)--Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the
"Company"), is pleased to announce the receipt of a Notice of Allowance
for its U.S. Patent Application No. 14/191,947 (US 2014/0295423 A1)
entitled Methods for Genetic Analysis of Textiles Made of Gossypium
barbadense and Gossypium hirsutum Cotton. The allowed patent
application, which will issue as a U.S. patent in the next few months,
significantly bolsters the Company’s patent protection for its
fiberTyping technology.

“With the
allowance of this patent application, we have now successfully protected
both means by which the chloroplast DNA of cotton fibers can be
analyzed, giving us a strong patent position in the cotton genotyping
market.”

The newly allowed ‘947 application protects the Company’s proprietary
methods of cotton species identification in a manufactured article via
the extraction and analysis of target sequences found in the chloroplast
DNA of the article. The allowed claims cover chloroplast DNA target
sequence analysis via all known sequence-specific DNA analysis
techniques, including qPCR (quantitative polymerase chain reaction) and
hybridization probe technologies.

With the addition of the allowed ‘947 application, the Company has been
granted 4 U.S. patents on its fiberTyping technology, which now cover
the identification of a cotton species in a manufactured article via
both target sequence and length polymorphism analysis of chloroplast
DNA. The Company plans to closely monitor cotton products imported into
the U.S. that allege to be verified via mature cotton fiber genotyping
analysis, and will act accordingly.

Dr. James Hayward, president and CEO of Applied DNA, noted, “With the
allowance of this patent application, we have now successfully protected
both means by which the chloroplast DNA of cotton fibers can be
analyzed, giving us a strong patent position in the cotton genotyping
market.” Dr. Hayward continued, “Our fiberTyping technology, coupled
with our patented SigNature® T molecular tags, are the
ultimate combination for the corroboration of cotton content label
claims. No other system can provide the immutable forensic level
identity and traceability proof our technology provides. With the recent
announcement of our GeoTyping™ technology, we are continuing to push the
boundaries of cotton genotyping science.”

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based
technology solutions and services that can help protect products,
brands, entire supply chains, and intellectual property of companies,
governments and consumers from theft, counterfeiting, fraud and
diversion. The proprietary DNA-based CertainT®
platform can be used to identify, tag, test, and track products, to help
assure authenticity, origin, traceability, sustainability and quality of
products.

SigNature® DNA describes the core technology ingredient that
is at the heart of a family of uncopyable, security and authentication
solutions such as SigNature®T and fiberTyping®,
targeted towards textiles and apparel, BackTrac®, DNAnet®
andSmartDNA® for anti-theft and loss
prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can be
used to prosecute perpetrators. Applied DNA Sciences is also engaged in
the large-scale production of specific DNA sequences using the
polymerase chain reaction.

The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe Applied
DNA’s future plans, projections, strategies and expectations, and are
based on assumptions and involve a number of risks and uncertainties,
many of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to our lack of
significant revenues, limited financial resources, limited market
acceptance, history of net losses, market competition and various other
factors detailed from time to time in Applied DNA’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December 28,
2017 and our subsequent quarterly report on Form 10-Q filed on February
8, 2018, which are available at www.sec.gov.
Applied DNA undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.